Hormonoresistance in advanced breast cancer: a new revolution in endocrine therapy by Augereau, Paule, Patsouris, Anne, Bourbouloux, Emmanuelle, Gourmelon, Carole, Abadie Lacourtoisie, Sophie, Berton Rigaud, Dominique, Soulié, Patrick, Frenel, Jean Sebastien, Campone, Mario

Get full text

Oxaliplatin-based hyperthermic intraperitoneal chemotherapy in primary or recurrent epithelial ovarian cancer: A pilot study of 31 patients by Frenel, Jean-Sebastien, Leux, Christophe, Pouplin, Luc, Ferron, Gwenael, Berton-Rigaud, Dominique, Bourbouloux, Emmanuelle, Dravet, François, Jaffre, Isabelle, Classe, Jean-Marc

Get full text

The CD47/TSP-1 axis: a promising avenue for ovarian cancer treatment and biomarker research by Moniot, Aurélie, Schneider, Christophe, Chardin, Laure, Yaniz-Galende, Elisa, Genestie, Catherine, Etiennot, Marion, Henry, Aubéri, Drelon, Coralie, Le Formal, Audrey, Langlois, Benoit, Venat, Laurence, Louvet, Christophe, Favier, Laure, Lortholary, Alain, Berton-Rigaud, Dominique, Dohollou, Nadine, Desauw, Christophe, Fabbro, Michel, Malaurie, Emmanuelle, Dubot, Coraline, Kurtz, Jean Emmanuel, Bonichon Lamichhane, Nathalie, Pujade-Lauraine, Éric, Jeanne, Albin, Leary, Alexandra, Dedieu, Stéphane

Get full text

Validation of the modified Glasgow Prognostic Score (mGPS) in recurrent ovarian cancer (ROC) – Analysis of patients enrolled in the GCIG Symptom Benefit Study (SBS) by Roncolato, Felicia T., Berton-Rigaud, Dominique, O'Connell, Rachel, Lanceley, Anne, Sehouli, Jalid, Buizen, Luke, Okamoto, Aikou, Aotani, Eriko, Lorusso, Domenica, Donnellan, Paul, Oza, Amit, Avall-Lundqvist, Elisabeth, Berek, Jonathan, Hilpert, Felix, Ledermann, Jonathan A., Kaminsky, Marie Christine, Stockler, Martin R., King, Madeleine T., Friedlander, Michael

Get full text

Phase I study of onapristone, a type I antiprogestin, in female patients with previously treated recurrent or metastatic progesterone receptor-expressing cancers by Cottu, Paul H, Bonneterre, Jacques, Varga, Andrea, Campone, Mario, Leary, Alexandra, Floquet, Anne, Berton-Rigaud, Dominique, Sablin, Marie-Paule, Lesoin, Anne, Rezai, Keyvan, Lokiec, François M, Lhomme, Catherine, Bosq, Jacques, Bexon, Alice S, Gilles, Erard M, Proniuk, Stefan, Dieras, Veronique, Jackson, David M, Zukiwski, Alexander, Italiano, Antoine

Get full text

Reducing Uncertainty: Predictors of Stopping Chemotherapy Early and Shortened Survival Time in Platinum Resistant/Refractory Ovarian Cancer—The GCIG Symptom Benefit Study by Roncolato, Felicia T., Joly, Florence, O'Connell, Rachel, Lanceley, Anne, Hilpert, Felix, Buizen, Luke, Okamoto, Aikou, Aotani, Eriko, Pignata, Sandro, Donnellan, Paul, Oza, Amit, Avall‐Lundqvist, Elisabeth, Berek, Jonathan S., Heitz, Florian, Feeney, Amanda, Berton‐Rigaud, Dominique, Stockler, Martin R., King, Madeleine, Friedlander, Michael

Get full text

"Chronic fatigue, quality of life and long-term side-effects of chemotherapy in patients treated for non-epithelial ovarian cancer: national case-control protocol study of the GINE... by Gernier, François, Ahmed-Lecheheb, Djihane, Pautier, Patricia, Floquet, Anne, Nadeau, Cédric, Frank, Sophie, Alexandre, Jérôme, Selle, Frédéric, Berton-Rigaud, Dominique, Kalbacher, Elsa, Orfeuvre, Hubert, Lortholary, Alain, Augereau, Paule, Labombarda, Fabien, Perrier, Lionel, Grellard, Jean-Michel, Licaj, Idlir, Clarisse, Bénédicte, Savoye, Aude-Marie, Bourien, Héloise, De La Motte Rouge, Thibaut, Kurtz, Jean-Emmanuel, Kerdja, Katia, Lelaidier, Anaïs, Charreton, Amandine, Ray-Coquard, Isabelle, Joly, Florence

Get full text

PIK3CA Pathway Mutations Predictive of Poor Response Following Standard Radiochemotherapy ± Cetuximab in Cervical Cancer Patients by de la Rochefordiere, Anne, Kamal, Maud, Floquet, Anne, Thomas, Laurence, Petrow, Peter, Petit, Thierry, Pop, Marius, Fabbro, Michel, Kerr, Christine, Joly, Florence, Sevin, Emmanuel, Maillard, Sophie, Curé, Hervé, Weber, Béatrice, Brunaud, Claire, Minsat, Mathieu, Gonzague, Laurence, Berton-Rigaud, Dominique, Aumont, Maud, Gladieff, Laurence, Peignaux, Karine, Bernard, Virginie, Leroy, Quentin, Bieche, Ivan, Margogne, Audrey, Nadan, AnaTereza, Fourchotte, Virginie, Diallo, Alhassane, Asselain, Benard, Plancher, Corine, Armanet, Sébastien, Beuzeboc, Philippe, Scholl, Suzy M

Get full text

Surgical Implications of Advanced Low-Grade Serous Ovarian Cancer: Analysis of the Database of the Tumeurs Malignes Rares Gynécologiques Network by Bonsang-Kitzis, Hélène, Panchbhaya, Nabilah, Bats, Anne-Sophie, Pujade-Lauraine, Eric, Pautier, Patricia, Ngô, Charlotte, Le Frère-Belda, Marie-Aude, Kalbacher, Elsa, Floquet, Anne, Berton-Rigaud, Dominique, Lefeuvre-Plesse, Claudia, Fabbro, Michel, Ray-Coquard, Isabelle, Lécuru, Fabrice

Get full text

Early Death in Advanced Ovarian Cancer in Older Adults by Lefur, Eloise, Berton-Rigaud, Dominique, Boureau, Anne S., Chapelet, Guillaume, Berrut, Gilles, de Decker, Laure

Get full text

A Double‐Blind, Randomized Phase II Study to Evaluate the Safety and Efficacy of Acetyl‐L‐Carnitine in the Prevention of Sagopilone‐Induced Peripheral Neuropathy by Campone, Mario, Berton‐Rigaud, Dominique, Joly‐Lobbedez, Florence, Baurain, Jean‐Francois, Rolland, Frédéric, Stenzl, Arnulf, Fabbro, Michel, Dijk, Marjan, Pinkert, Jörg, Schmelter, Thomas, Bont, Natasja, Pautier, Patricia

Get full text

268 A phase 1 study of retifanlimab (INCMGA00012), a PD-1 inhibitor, in patients with advanced solid tumors: preliminary results in recurrent MSI-high or dMMR endometrial cancer (P... by Berton-Rigaud, Dominique, Vergote, Ignace, Pautier, Patricia, Kryzhanivska, Anna, Angelergues, Antoine, Kornacki, Deanna, Dudzisz-Sledz, Monika, Tian, Chuan, Bourayou, Nawel, Selle, Frederic

Get full text

Pembrolizumab in patients with programmed death ligand 1–positive advanced ovarian cancer: Analysis of KEYNOTE-028 by Varga, Andrea, Piha-Paul, Sarina, Ott, Patrick A., Mehnert, Janice M., Berton-Rigaud, Dominique, Morosky, Anne, Yang, Ping, Ruman, Jane, Matei, Daniela

Get full text

NY-ESO-1-specific circulating CD4+ T cells in ovarian cancer patients are prevalently T(H)1 type cells undetectable in the CD25+ FOXP3+ Treg compartment by Redjimi, Nassima, Duperrier-Amouriaux, Karine, Raimbaud, Isabelle, Luescher, Immanuel, Dojcinovic, Danijel, Classe, Jean-Marc, Berton-Rigaud, Dominique, Frenel, Jean-Sébastien, Bourbouloux, Emmanuelle, Valmori, Danila, Ayyoub, Maha

Get full text

Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised,... by de Boer, Stephanie M, Powell, Melanie E, Mileshkin, Linda, Katsaros, Dionyssios, Bessette, Paul, Haie-Meder, Christine, Ottevanger, Petronella B, Ledermann, Jonathan A, Khaw, Pearly, Colombo, Alessandro, Fyles, Anthony, Baron, Marie-Helene, Jürgenliemk-Schulz, Ina M, Kitchener, Henry C, Nijman, Hans W, Wilson, Godfrey, Brooks, Susan, Carinelli, Silvestro, Provencher, Diane, Hanzen, Chantal, Lutgens, Ludy C H W, Smit, Vincent T H B M, Singh, Naveena, Do, Viet, D'Amico, Romerai, Nout, Remi A, Feeney, Amanda, Verhoeven-Adema, Karen W, Putter, Hein, Creutzberg, Carien L, McCormack, Mary, Whitmarsh, Karen, Allerton, Rozenn, Gregory, Deborah, Symonds, Paul, Hoskin, Peter J., Adusumalli, Madhavi, Anand, Anjana, Wade, Robert, Stewart, Alexandra, Taylor, Wendy, Kruitwagen, Roy F.P.M., Hollema, Harry, Pras, Elizabeth, Snyers, An, Stalpers, Lukas, Jobsen, Jan J., Slot, Annerie, Mens, Jan-Willem M., Stam, Tanja C., Van Triest, Baukelien, Van der Steen - Banasik, Elzbieta M., De Winter, Karin A.J., Quinn, Michael A., Kolodziej, Ilka, Pyman, Jan, Johnson, Carol, Capp, Anne, Fossati, Roldano, Gribaudo, Sergio, Lissoni, Andrea A., Ferrero, Annamaria, Artioli, Grazia, Davidson, Cathy, McLachlin, C. Meg, Ghatage, Prafull, Rittenberg, Paula V.C., Souhami, Luis, Thomas, Gillian, Duvillard, Pierre, Berton-Rigaud, Dominique, Tubiana-Mathieu, Nicole

Get full text

Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial by Oza, Amit M, Prof, Cook, Adrian D, MSc, Pfisterer, Jacobus, Prof, Embleton, Andrew, MSc, Ledermann, Jonathan A, Prof, Pujade-Lauraine, Eric, Prof, Kristensen, Gunnar, Prof, Carey, Mark S, MD, Beale, Philip, MD, Cervantes, Andrés, Prof, Park-Simon, Tjoung-Won, Prof, Rustin, Gordon, Prof, Joly, Florence, Prof, Mirza, Mansoor R, MD, Plante, Marie, MD, Quinn, Michael, Prof, Poveda, Andrés, MD, Jayson, Gordon C, Prof, Stark, Dan, MD, Swart, Ann Marie, Prof, Farrelly, Laura, MSc, Kaplan, Richard, Prof, Parmar, Mahesh K B, Prof, Perren, Timothy J, Prof

Get full text

A phase 1 study of lirilumab (antibody against killer immunoglobulin-like receptor antibody KIR2D; IPH2102) in patients with solid tumors and hematologic malignancies by Vey, Norbert, Karlin, Lionel, Sadot-Lebouvier, Sophie, Broussais, Florence, Berton-Rigaud, Dominique, Rey, Jérôme, Charbonnier, Aude, Marie, Delphine, André, Pascale, Paturel, Carine, Zerbib, Robert, Bennouna, Jaafar, Salles, Gilles, Gonçalves, Anthony

Get full text

Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial by Shannon, Catherine M, Joly, Florence, Sehouli, Jalid, Canzler, Ulrich, Schmalfeldt, Barbara, Dean, Andrew P, Hein, Alexander, Zeimet, Alain G, Petit, Thierry, Marmé, Frederik, El-Balat, Ahmed, Glasspool, Rosalind, Mahner, Sven, Park-Simon, Tjoung-Won, Mouret-Reynier, Marie-Ange, Costan, Cristina, Reinthaller, Alexander, Goh, Jeffrey C, Kommoss, Stefan, Kurtz, Jean-Emmanuel, Ackermann, Sven, Anthuber, Christoph, Aydogdu, Mustafa, Baldauf, Angelika, Behringer, Dirk, Belau, Antje, Bender, Alexandra, Burges, Alexander, Canzler, Ulrich, Daabach, Trygve, Deryal, Mustafa, El-Balat, Ahmed, Fehm, Tanja, Feisel-Schwickardi, Gabriele, Frank, Matthias, Gebauer, Gerhard, Gerber, Bernd, Gerhardt, Axel, Grafe, Andrea, Griesshammer, Martin, Gropp-Meier, Martina, Hager, Dietrich, Hannig, Carla Verena, Hantschmann, Peer, Harter, Philipp, Hauzenberger, Tanja, Herwig, Uwe, Hilpert, Felix, Jackisch, Christian, Krieger, Peter, Lampe, Björn, Lex, Benno, Lorenz, Ralf, Mahner, Sven, Mallmann, Peter, Marmé, Frederik, Möbus, Volker, Müller, Thomas, Neunhöffer, Tanja, Ober, Angelika, Rautenberg, Beate, Reiter, Wilhelm, Schmalfeldt, Barbara, Scholz, Heinz, Simon, Eike, Sperfeld, Antje, Terhaag, Jürgen, Uleer, Christoph, Vogel, Susanne, Voß, Hermann, Winkler, Ulrich, Wischnik, Arthur, Zorr, Andreas, Glasspool, Ros, Jones, Rachel, Lafleur, Judith, Marth, Christian, Baron-Hay, Sally, Beale, Philip, Begbie, Stephen, Harvey, Sandra, Matos, Marco, Meniawy, Tarek, Olesen, Inger, Shannon, Catherine, Abadie-Lacourtoisie, Sophie, Arsene, Olivier, Barthier, Sophie, Catala, Stéphanie, Dohollou, Nadine, Garnier-Tixidré, Claire, Guardiola, Emmanuel, Hardy-Bessard, Anne-Claire, Joly, Florence, Levache, Charles-Briac, Longo, Raffaele, Lortholary, Alain, Meunier, Jérôme, Raban, Nadia, Vannetzel, Jean-Michel

Get full text

Influence of the time between surgery and radiotherapy on local recurrence in patients with lymph node-positive, early-stage, invasive breast carcinoma undergoing breast-conserving... by BENCHALAL, Mohamed, LE PRISE, Elisabeth, GOUDIER, Marie-Josèphe, MARCHAI, Christian, CHOLLET, Philippe, ABADIE-LACOURTOISIE, Sophie, DATCHARY, Jean, VEYRET, Corinne, KERBRAT, Pierre, DE LAFONTAN, Brigitte, BERTON-RIGAUD, Dominique, BELKACEMI, Yazid, ROMESTAING, Pascale, PEIGNAUX, Karine, COURDI, Adel, MONNIER, Alain, MONTCUQUET, Philippe

Get full text

Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial by du Bois, Andreas, Prof, Kristensen, Gunnar, Prof, Ray-Coquard, Isabelle, Prof, Reuss, Alexander, MSc, Pignata, Sandro, MD, Colombo, Nicoletta, Prof, Denison, Ursula, MD, Vergote, Ignace, Prof, del Campo, Jose M, MD, Ottevanger, Petronella, PhD, Heubner, Martin, MD, Minarik, Thomas, PhD, Sevin, Emmanuel, MD, de Gregorio, Nikolaus, MD, Bidziński, Mariusz, Prof, Pfisterer, Jacobus, Prof, Malander, Susanne, MD, Hilpert, Felix, Prof, Mirza, Mansoor R, MD, Scambia, Giovanni, Prof, Meier, Werner, Prof, Nicoletto, Maria O, MD, Bjørge, Line, Prof, Lortholary, Alain, MD, Sailer, Martin Oliver, PhD, Merger, Michael, MD, Harter, Philipp, MD

Get full text